ArticlePharmacoEconomics - open2026

Cost-Effectiveness Analysis of Etrasimod Compared With Biologic Therapies for the Treatment of Patients with Moderately-to-Severely Active Ulcerative Colitis in Spain.

Iago Rodríguez-Lago et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.